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Transthoracic ultrasoundAbstract Introduction: Lung cancer is one of the leading causes of cancer-related deaths in the
world and early detection and proper staging are highly important for planning of treatment strat-
egy.
Aim of the work: To study the possible added value of transthoracic ultrasound (TUS) in staging
of lung cancer.
Patients and methods: The study was carried out at Chest Department, Kasr El-Aini hospital in
the period from April 2012 to December 2012. TUS was carried out on 50 cases with primary lung
cancer after revision of CT chest images.
Results: TUS was only able to detect pulmonary masses in 31 cases (they had an ultrasound
(US) window to reach the tumor mass). The study found that TUS was more able to detect more
cases with chest wall invasion than CT chest and it was able to differentiate between visceral and
parietal pleural invasion. It was also not only more able to detect the presence of pleural ﬂuid ency-
station than CT scan detection but also was more able to further characterize its type. Diaphrag-
matic mobility was also assessed by TUS. There was also a statistical signiﬁcant difference
between TUS and CT chest in detecting consolidation and/or collapse.
Conclusion: TUS is complementary and adding a value to both clinical and computerized tomo-
graphic diagnoses of lung cancer. It can help in staging of lung cancer and aid chest physicians in
determining the modality of treatment in each patient depending on his/her stage.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.Introduction
Lung cancer is one of the leading causes of cancer-related
deaths in the world. Invasion of the parietal pleura, the visceral
pleura, or the bony structure of the chest wall occurs in 5–8%
of patients with non-small cell lung cancer who are undergoing
surgical treatment, and alters the TNM classiﬁcation, staging,
and planned treatment approaches. Therefore, it is important
to determine the extent of disease prior to surgery, as this will
impact disease management and prognosis [1].
Table1 Clinical characteristic of the study population.
No. Age (mean ± SD) Sex Diagnosis
Male Female NSCLC SCLC
50 58.52 ± 9.19 43 7 46 4
Table2 Assessment of chest wall invasion, visceral pleural invasion and parietal pleural invasion.
Total cases Chest wall invasion by CT Chest wall invasion by US Visceral pleural invasion by US Parietal pleural invasion by US
31 No. % No. % No. % No. %
5 16.1 9 29 17 54.8 14 45.1
Table 3 Presence of effect (collapse and consolidation) by US & CT.
Modality Eﬀect No Eﬀect Total P-Value
Collapse Consolidation Collapse
& consolidation
CT 8 1 0 41 50 P< 0.001*
TUS 13 2 4 31
* Signiﬁcant at P< 0.001.
Table 4 Detection of pleural ﬂuid encystations by CT and TUS.
Modality Free eﬀusion Encysted eﬀusion P-Value
CT 12 4 0.013
TUS 5 11




Diaphragm mobility by US Mobile 6 39 45
Immobile 1 4 5
Total 7 43 50
Table 6 Comparison between clinical detection and US detection of supraclavicular lymph node.
Modality LN present LN absent Total P-Value
Clinical detection 2 48 50 0.008
US detection 5 45
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Table 7 T Stage after US and before U/S.
In assessment of T Stage after US and before U/S there was no
change in 39 cases with total agreement = (11 + 5 + 17 + 6) /
50 = 78%, 9 cases changed to a more advanced stage after TUS
and 2 cases changed to a less advanced stage after TUS.
Down staging by US = 2/50 = 4%.
Up staging by US= (2 + 5 + 2)/50 = 18%.
Table 8 Overall Stage after US and before U/S in 50 patients.
In assessment of the overall Stage after US and before US there was
no change in 45 cases with total agreement = (7 + 5 + 7+ 11
+ 2 + 13)/50 = 90%.
Five cases changed to a more advanced stage after TUS due to the
change of T stage.
Up staging by US= (1 + 1 + 1+ 1+ 1)/50 = 10%.
Study of the added value of transthoracic ultrasound in staging of lung cancer 1027The pre-operative evaluation in patients who will undergo
operative staging or resection for lung cancer is multidimen-
sional and involves detailed history taking, physical examina-
tion and review of imaging studies. Two important elements
of both staging and pre-operative evaluations include the
evaluation of: [1] the pleural space for the presence of malig-
nant pleural effusion and [2] the diaphragm for appropriate
movement. At this point in time, the pleural space evaluation
is being performed using CT scan which does not allow the
acquisition of real-time cytological material from pleural
effusions due to the fact that the CT scans are done in a
diagnostic setting.
Malignant pleural effusion is recognized as a poor prognos-
ticator in non-small cell lung cancer patients and has recently
been upgraded from a T4 to an M1a status [2].
Also diaphragmatic movement/excursion is not currently
being assessed pre-operatively and its impact on staging and
post-operative pulmonary function is unknown. Recognizing
the stage early allows for more precise prognostication ofdisease and can lead to precision and streamlining of treatment
plans for thoracic surgeons and oncologists [3].
The role of ultrasonography in the diagnosis and manage-
ment of different diseases is rapidly changing due to changes
in technology in the competing modalities, such as computed
tomography and magnetic resonance imaging.
Aim of the work
To assess the added value of transthoracic ultrasonography in
staging of lung cancer.
Subjects and methods
A prospective study that was conducted at Chest Depart-
ment, Kasr El-Aini hospital, Cairo University, in the period
from April 2012 to December 2012. Fifty patients with con-
ﬁrmed diagnosis of primary lung cancer were involved in
the study.
After assessment of the ﬁnding on CT chest, detailed
transthoracic evaluation was carried out using ultrasound
equipment model HITACHI EUB 7000 and ultrasound
probes with different frequencies (Convex probe 2–5 MHz,
Mini convex probe 4–8 MHz, Linear probe 9–13 MHz). As
a coupling medium water soluble ultrasound transmission
gel was applied to the skin.US examination was performed
with the patient in the supine or sitting position, according
to the site of the lesion. The lung and the pleura were evalu-
ated through longitudinal and oblique intercostal transducer
application.
Diaphragmatic motion was examined while the patient
remained in supine position in the longitudinal semi-coronal
plane from a subcostal or low intercostal approach using
M-mode ultrasonography.
Diagnostic thoracocentesis was performed for cases with
detected pleural effusion, using ﬁne 20 gauge needles and
the ﬂuid was sent for chemical and cytological analyses.
Supraclavicular lymph nodes were examined while the
patient was placed in a supine position with the neck
hyperextended. Enlarged nodes were aspirated with ﬁne 20
gauge needles or biopsied via true-cut 18 gauge needle.
Statistical analysis
Data were statistically described in terms of mean ± standard
deviation (±SD), number of cases, and percentages when
appropriate. Chi-square test/ﬁsher exact test was used for com-
paring categorical data. Cases having the same stage were cal-
culated as a percentage of the total cases examined, to detect
the percentage of agreement. P value was signiﬁcant if less
or equal than 0.05. All statistical calculations were done using
computer programs SPSS (Statistical Package for the Social
Science; SPSS Inc., Chicago, IL, USA) version 15 for Micro-
soft windows.
Results
Results are discussed in Tables 1–8.
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Case (1): Peripheral mass with intact visceral and parietal
pleura
Chest X-ray: Fig. (1a)CT chest: Fig. (1b)Transthoracic ultrasound: Fig. (1c)
Study of the added value of transthoracic ultrasound in staging of lung cancer 1029Case (2): Peripheral mass with chest wall invasion and rib
erosion
Chest X-ray: Fig. (2a)CT chest: (Fig. 2b)Transthoracic ultrasound: (Fig. 2c)
1030 H.A. Abu-Youssef et al.Case (3): TUS showing mass in the right mammary region and
right pleural effusion with small right scalene LN
Chest X-ray: (Fig. 3a)CT chest: (Fig. 3b)Transthoracic ultrasound: (Fig. 3c)
Study of the added value of transthoracic ultrasound in staging of lung cancer 1031Case (4): TUS showing complex septated pleural effusion with
underlying consolidation collapse of the lung and a
diaphragmatic pleural nodule
Chest X-ray: (Fig. 4a)CT chest: (Fig. 4b)Transthoracic ultrasound: (Fig. 4c)
1032 H.A. Abu-Youssef et al.Case (5): Metastatic lung cancer with TUS showing right
suprarenal mass and left scalene lymph node
Chest X-ray: (Fig. 5a)CT chest: (Fig. 5b)Transthoracic ultrasound: (Fig. 5c)Discussion
The study was carried out at Chest department, Kasr El-Aini
hospital, Cairo University in the period from April 2012 to
December 2012. It included ﬁfty patients with conﬁrmed diag-
nosis of primary lung cancer. TUS was performed for all cases
after careful revision of CT images.The clinical characteristics of the study population are
shown in Table 1. Forty six cases were diagnosed as NSCLC
and 4 cases as SCLC. The ﬁnal pathological diagnosis was
obtained in 30 cases via ﬁberoptic bronchoscopy, 17 cases
via sonar guided biopsy from the lung mass,1 case via sonar
guided biopsy from supraclavicular lymph node, 1 via CT
guided biopsy, and 1 via thoracoscopic lung biopsy.
Study of the added value of transthoracic ultrasound in staging of lung cancer 1033TUS was only able to detect pulmonary masses in 31 cases
(62%) (they had an US window to reach the tumor mass) and
there was no statistically signiﬁcant difference between CT
chest and TUS as regards the size of the mass (P-value:
0.155). The difference between the size detected by CT and
TUS was due to the ability of US to differentiate the tumor
from the surrounding lung consolidation and/or collapse. Also
there was no statistical signiﬁcant difference between CT chest
and TUS as regards the shape, and the margin of the lesion
with P-values 0.430 and 0.200 respectively.
The main ﬁnding of our study is that, TUS was able to
detect more cases with chest wall invasion than CT chest and
it was more able to detect visceral and parietal pleural invasion
(Table 2).
Sugama et al. [4] found that the total accuracy of TUS in
detection of pleura and chest wall invasion was 77% which
was important regarding decisions of surgical interventions
and stated that this approach could delineate cancerous inva-
sion into the pleura and chest wall sufﬁciently well for staging
of patients with lung cancer.
Bandi et al. [1] carried out a study to evaluate the role of
ultrasound in determining chest wall involvement in lung can-
cer compared to CT scan and surgery and found that, ultra-
sound is more sensitive than CT scanning in the evaluation
of chest wall invasion and compliments CT scan data and con-
cluded that ultrasound has better sensitivity (89%) and speci-
ﬁcity (95%) in assessing chest wall involvement by a lung
tumor compared to CT scan examination (sensitivity, 42%;
speciﬁcity, 100%).
Also Chira et al. [5] carried out a study to compare ultraso-
nographic and computed tomography in intrathoracic tumors
in contact with the chest wall and concluded that, the sensitiv-
ity and speciﬁcity of US in diagnosing chest wall invasion of
malignant lesions are superior to those of CT.
In our study, we found that TUS is more able to detect the
presence of consolidation and/or collapse than CT chest with
highly statistically signiﬁcant difference (P-value <0.001).
This is particularly important as it has an impact on T stage
of lung cancer (Table 3).
As regards assessment of pleural effusion, it was found that
there was no statistical difference between TUS and CT in the
detection of pleural effusion with P value = 0.534. In our
study TUS and CT were well correlated in the detection of
pleural effusion (r= 0.792) and in determining its amount
(r= 0.854). However ultrasound is more able to detect the
presence of encystation than CT scan detection with P
value = 0.013 (Table 4).
Also TUS was helpful in characterization of the effusion.
Free effusion was present in 8 cases, complex non-septated
effusion in 8 cases, complex septated in 3 cases, and one
case with anechoic effusion. There was a statistical signiﬁ-
cance difference between TUS and CT in characterization
of pleural effusion (P< 0.001). This was in agreement with
Kurian et al. [6] who stated that although chest ultrasound
may be limited by its small ﬁeld of view and shadowing
of deep structures by overlying air, yet it was equally able
to detect pleural ﬂuid and loculation when compared with
CT chest. TUS was superior to chest CT in its ability to
resolve the internal components of pleural ﬂuid including
ﬁbrin strands.In assessment of diaphragmatic mobility, ﬁve cases were
found to have diaphragmatic immobility which could not be
detected by CT.
This was in agreement with a study done by Gerscovich
et al. [7] to evaluate diaphragmatic motion by US and con-
cluded that US is feasible and useful in evaluating diaphrag-
matic motion and that it could replace ﬂuoroscopy as it has
advantages over traditional ﬂuoroscopy.
In assessing diaphragmatic mobility in relation to elevated
copula by CT it was found that only 1 case out of 7 cases with
elevated copula by CT had diaphragmatic immobility by US
and the other 6 cases had freely mobile diaphragm as shown
in Table 5.
Regarding the assessment of nodal involvement, TUS was
used to assess only supra-clavicular lymph node (N3). It was
detected clinically in 2 patients, and was detected by ultra-
sound in 5 patients (10% of cases) including the 2 cases
detected clinically, with a signiﬁcant statistical difference
(P= 0.008) (Table 6). Pathological diagnosis of metastatic
lung cancer was achieved in 1 case via true cut needle biopsy
from the detected lymph node. Fultz et al. [8] stated that
US-guided FNA of supraclavicular lymph nodes is a simple
and safe procedure that can usually be performed by a single
operator. Also Kumaran et al. [9] conﬁrmed that Ultrasound
guided FNAC is a promising, relatively non-invasive technique
for the staging and diagnosis of patients with lung cancer. In
agreement to our results, Overhagen et al. [10] stated that
the sensitivity of palpation, CT, and neck US in detecting
supraclavicular lymph node was reported as 33%, 83%, and
100%, respectively.
The impact of ultrasonography-guided ﬁne needle aspira-
tion of no palpable supraclavicular lymph nodes on diagnosis
and staging in advanced lung cancer was also studied by
Ozkan et al. [11], and conﬁrmed that US-guided FNA is an
easier, safer, and less invasive procedure than standard tech-
niques used to diagnose lung cancer patients with enlarged
mediastinal lymph nodes.
Table 7 shows the T stage before transthoracic ultrasound
when compared to the T stage after transthoracic ultrasound
in all 50 cases of the study group. Eighteen cases were in stage
T2a before TUS; 2 cases were upstaged to T2b by changing the
size of the mass and 5 cases were upstaged to stage T3; one
case by detecting immobile diaphragm and 4 cases by detecting
parietal pleura and chest wall invasion by TUS. Seven cases
were found in stage T2b before TUS, after TUS 2 cases were
upstaged to T3 by detecting parietal pleura and chest wall
invasion and one case was downstaged to T2b by measuring
a smaller size of the lesion. One case out of the 7 cases in stage
T4 was downstaged to T2a after TUS as it could not detect
bilateral nodules. The difference in the size of the lesion
detected by CT to that detected by TUS could be explained
by the change of the plane of viewing the image via TUS.
In assessment of the N and M stages in all 50 cases of the
study group, no difference was detected after TUS with a total
agreement of 100% with the following N stage; 31 cases (62%)
were in stage N0, 7 cases (14%) were in stage N1, 10 cases
(20%) were in N2 stage and only 2 cases (4%) were in N3
stage, and as regards the M stage; 37 cases (74%) were in
M0, 5 cases (10%) were in M1a stage and 8 cases (16%) were
in M1b stage.
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group showed that, ﬁve cases upstaged due to the change in
the T stage where 2 cases in stage 1b were upstaged; one case
to 2a, and another case to 2b, another 2 cases in stage 2a were
upstaged; one case to 2b, and another one to 3a, also one case
in stage 2b was upstaged to 3a.
Hoosein et al. [12] studied the importance of US in staging
and gaining a pathological diagnosis in patients with lung can-
cer and reported that the use of ultrasound gives a rapid and
less invasive method of diagnosing and staging lung cancer
and has become introduced into the diagnostic pathway in
patients with lung cancer.
According to our ﬁndings the use of TUS appears as an
easy and safe diagnostic tool for cases with lung cancer and
can be not only complementary to both clinical and computer-
ized assessment, but with important added value.
The following limitations of the study worth attention; 1st,
The necessity to have a rather large wall contact in order to
completely analyze a lesion or to perform US guided biopsy
is important. Also the accuracy of TUS in detection of tumor
size and subsequently changing the T descriptor is question-
able, because more advanced imaging modalities are superior
in size determination. 2nd, accurate pleural and chest wall
invasion should be conﬁrmed by post-surgical staging,
And lastly, TUS was limited to assess only supraclavicular
lymph node as mediastinal nodal involvement cannot be
assessed by transthoracic ultrasound except if ultrasound win-
dow is available, taking into consideration that more advanced
non-invasive methods can be used as PET and MRI or inva-
sive techniques such as EUS and mediastinoscopy that were
not used during staging.
Conclusion
Transthoracic ultrasound can help in staging of lung cancer
and aid chest physicians in determining the modality of treat-
ment in each patient depending on his/her stage and accord-
ingly, it should be implemented in the diagnostic work up of
patients with primary lung cancer.
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